3. Current or recurrent disease that could affect the action, absorption, disposition, or laboratory assessment of the investigational product (IP) (including bile salt metabolism in the intestine) e.g, uncontrolled inflammatory bowel disease, uncontrolled celiac disease, gastric bypass procedures (gastric lap band or gastric sleeve is acceptable), ileal or ileocecal resection, uncontrolled irritable bowel syndrome with predominant diarrhea, or history of chronic diarrhea or loose stools of any etiology.